Skip to content
Open Data Finder
Open Government Canada

Canada’s regulatory approach to drugs for rare diseases: orphan drugs

Published by Health Canada | Santé Canada

About this dataset

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.

Canada’s regulatory approach to drugs for rare diseases: orphan drugs · Open Data Finder